CORRECTING and REPLACING -- Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics
(WorldNews Health)

CORRECTING and REPLACING -- Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics October 10, 2019 CHARLOTTE, N.C. and PRINCETON, N.J., Oct. 10, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Chanticleer Holdings, Inc. (Nasdaq: BURG), please note that the conference call date is October 11, 2019, not October 10, 2019 as previously stated. The corrected release follows: - Transaction to Accelerate Sonnet`s Growing Pipeline of Oncology Candidates - - Initiation of Two New Clinical Programs Expected in 2020 - - Strategic Expansion of Sonnet`s Proprietary Platform - - Chanticleer to...